APA (7th ed.) Citation

Y, R., C, W., PW, M., & CA, B. (2026). Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery: Defining a unique acute immune landscape. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04353-1

Chicago Style (17th ed.) Citation

Y, Ramdas, Worsley C, Meyer PW, and Benn CA. "Modulation of HMGB1, PRF1, TRAIL, and M-CSF After TARGIT-IORT in Breast-conserving Surgery: Defining a Unique Acute Immune Landscape." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04353-1.

MLA (9th ed.) Citation

Y, Ramdas, et al. "Modulation of HMGB1, PRF1, TRAIL, and M-CSF After TARGIT-IORT in Breast-conserving Surgery: Defining a Unique Acute Immune Landscape." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04353-1.